Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Kearney

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Antiviral Therapy|February 19, 2013
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonistUri Lopatin, Grushenka Wolfgang, Daniel Tumas, et al.
HIV Clinical Trials|August 30, 2008
Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once dailyRichard Elion, Calvin Cohen, Douglas Ward, et al.
Journal of Affective Disorders|December 31, 2015
Are manic symptoms that 'dip' into depression the essence of mixed features?Gin S Malhi, Kristina Fritz, Christine Allwang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2013
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of lifeMark Mirochnick, Taha Taha, Regis Kreitchmann, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsPatricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
BMC Infectious Diseases|August 1, 2008
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cellsRina Das, Rasha Hammamieh, Roger Neill, et al.
Emerging Infectious Diseases|June 23, 2020
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol SuspensionsAlyssa C Fears, William B Klimstra, Paul Duprex, et al.
Science Advances|July 8, 2016
Reduced evolutionary rate in reemerged Ebola virus transmission chainsDavid J Blackley, Michael R Wiley, Jason T Ladner, et al.
Plos One|February 2, 2021
Development of a coronavirus disease 2019 nonhuman primate model using airborne exposureSara C Johnston, Keersten M Ricks, Alexandra Jay, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antiviral Therapy|February 19, 2013
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonistUri Lopatin, Grushenka Wolfgang, Daniel Tumas, et al.
HIV Clinical Trials|August 30, 2008
Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once dailyRichard Elion, Calvin Cohen, Douglas Ward, et al.
Journal of Affective Disorders|December 31, 2015
Are manic symptoms that 'dip' into depression the essence of mixed features?Gin S Malhi, Kristina Fritz, Christine Allwang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2013
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of lifeMark Mirochnick, Taha Taha, Regis Kreitchmann, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsPatricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
BMC Infectious Diseases|August 1, 2008
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cellsRina Das, Rasha Hammamieh, Roger Neill, et al.
Emerging Infectious Diseases|June 23, 2020
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol SuspensionsAlyssa C Fears, William B Klimstra, Paul Duprex, et al.
Science Advances|July 8, 2016
Reduced evolutionary rate in reemerged Ebola virus transmission chainsDavid J Blackley, Michael R Wiley, Jason T Ladner, et al.
Plos One|February 2, 2021
Development of a coronavirus disease 2019 nonhuman primate model using airborne exposureSara C Johnston, Keersten M Ricks, Alexandra Jay, et al.
Pageof 2